Journal and Highly Cited Data on the InCites platform

Remember this trial will end soon! Your feedback is most welcome.

Electronic Collection Management

Trial access ends to the replacement of the current version of the Journal Citation Reports and Essential Science Indicators on 30 September 2014.

Journal and Highly Cited Data(the module name for Journal Citation Reports – JCR, and Essential Science Indicators – ESI) is now on the InCites platform which offers a much greater ease of use and flexibility for analysing and presenting citation data to support research (and ultimately to support the REF 2020).

Read more about the trial here: http://wok.mimas.ac.uk/news/2014/20140513.html

Access the new JCR here http://jcr.incites.thomsonreuters.com/

Access the new ESI here: http://esi.incites.thomsonreuters.com/

Click on “Continue without loggin in” if this is your first visit.  Please note this trial is only available on campus via a PC on the University network.

Please send your feedback to eresources@lib.cam.ac.uk.   Thank you.

View original post

Reaxys Medicinal Chemistry trial

Yes please do send your feedback to me!

Electronic Collection Management

The University of Cambridge has trial access to Reaxys Medicinal Chemistryuntil 31 October 2014.

Access Reaxys Medicinal Chemistry via the Reaxys interface here.

Please send your feedback on the trial to cmc32@cam.ac.uk

Reaxys Medicinal Chemistrycombines the Reaxys chemistry database with tools for hitset assessment and data export.  It is designed to support researchers in making connections between compounds, targets, and bioactivity, allowing rapid early-stage drug candidate assessment.

View original post